Since 2019, Alchemy + Aim (A+A) has worked with On Target Laboratories to build and launch three website, including two Food and Drug Administration (FDA)-approved websites. A+A provided technical solutions to elevate their online presence, achieve regulatory and legal compliance for their websites, connect with potential patients, and educate the providers. Learn how A+A supports websites for startups, from design to compliance.
A+A and On Target Laboratories have collaborated since 2019 to build multiple websites to educate and inform the public, patients, and surgeons about CYTALUX®, a medical technology designed to illuminate cancer intraoperatively during removal. Here’s a snapshot of how we’ve worked together over the years:
On Target Laboratories engages A+A to construct and launch a series of websites supporting their groundbreaking medical technology, including a company website, a patient-centric website, and a website tailored for surgeons.
A+A develops and launches the new On Target Laboratories website.
A+A launches the CYTALUX® websites tailored for patients and healthcare providers.
A+A rolls out updates and enhancements to the CYTALUX® websites.
A+A provides strategic consultations during the FDA approval process for the CYTALUX® websites, including capturing and annotating all webpage language and imagery for FDA review.
A+A implements extensive changes on the CYTALUX® websites and launches updated website versions to meet regulatory and legal requirements.
A+A built a password-protected media resources page for public education purposes.